Patent directory · USPTO A61K / A61P
Patents matching “REGENERON PHARMACEUTICALS, INC.”
837 pharma patents match "REGENERON PHARMACEUTICALS, INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 837 pharmaceutical patents matching "REGENERON PHARMACEUTICALS, INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11274342
Systems and methods for sequencing T cell receptors and uses thereof
granted -
US 11267893
Anti-IL36R antibodies
granted -
US 11261248
Restricted immunoglobulin heavy chain mice
granted -
US 11253572
Use of a VEGF antagonist to treat angiogenic eye disorders
granted -
US 11254752
Methods for treating cancer with bispecific anti-CD3xMUC16 antibodies and anti-PD-1 antibodies
granted -
US 11248044
Methods for altering body composition by administering a GDF8 inhibitor and an Activin A inhibitor
granted -
US 11241498
Room temperature stable lyophilized protein
granted -
US 11241499
Human serum albumin in formulations
granted -
US 11214621
Methods for treating chronic sinusitis with nasal polyps by administering an IL-4R antagonist
granted -
US 11208458
Compositions and methods for internalizing enzymes
granted -
US 11191844
Multispecific antigen-binding molecules and uses thereof
granted -
US 11186625
Anti-VEGF protein compositions and methods for producing the same
granted -
US 11180540
Anti-VEGF protein compositions and methods for producing the same
granted -
US 11178860
Humanized C5 animals
granted -
US 11174305
Human antibodies to Fel d1 and methods of use thereof
granted -
US 11174283
Anti-VEGF protein compositions and methods for producing the same
granted -
US 11168111
Readily isolated bispecific antibodies with native immunoglobulin format
granted -
US 11167004
Methods for treating severe atopic dermatitis by administering an IL-4R inhibitor
granted -
US 11155633
Anti-PSMA antibodies, bispecific antigen-binding molecules that bind PSMA and CD3, and uses thereof
granted -
US 11155621
Anti-CD3 antibodies, bispecific antigen-binding molecules that bind CD3 and CD20, and uses thereof
granted -
US 11155598
GPR156 variants and uses thereof
granted -
US 11142578
Anti-MET antibodies, bispecific antigen binding molecules that bind MET, and methods of use thereof
granted -
US 11130999
Cas-ready mouse embryonic stem cells and mice and uses thereof
granted -
US 11129903
Multispecific antigen-binding molecules and uses thereof
granted